)
Tivic Health Systems (TIVC) investor relations material
Tivic Health Systems Investor Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic transformation and acquisition
Transitioned from consumer health tech to vertically integrated immunotherapeutics, acquiring manufacturing and development assets to support commercialization of drug candidates and forming the Velocity BioWorks subsidiary.
Acquisition of Scorpius Biomanufacturing assets for $16 million enabled in-house cGMP manufacturing, reducing reliance on external CDMOs and accelerating development timelines.
Achieved significant milestones, including a 200x engineering scale-up and the ability to produce tens of millions of doses annually.
Velocity BioWorks will serve both internal needs and third-party clients, unlocking new revenue streams and supporting rapid clinical advancement.
Operational and financial impact
In-house manufacturing slashes costs and eliminates long wait times, with estimated savings of $10 million before BLA filing and even greater savings over the product lifecycle.
Facility acquired for $16 million would have cost $80–$100 million to build from scratch, providing a significant capital advantage.
Production capacity exceeds 20 million doses of Entolimod annually, with expansion potential and revenue capacity in the billions.
Financing package includes $18 million upfront and access to $75 million in preferred convertible equity, supporting execution of the 2026 strategy.
Market positioning and growth opportunities
Velocity BioWorks targets the fast-growing biologics CDMO market, projected to reach $145 billion by 2037, with a focus on early-stage biotech clients facing capacity constraints.
Facility can serve 15–20 concurrent client programs, with potential annual revenue of $70 million at full capacity.
Positioned to benefit from rising demand for monoclonal antibodies, biosimilars, and cell/gene therapies, as well as demographic trends driving pharmaceutical growth.
U.S.-based manufacturing strengthens relationships with government agencies and supports supply chain security, enhancing prospects for government contracts.
Next Tivic Health Systems earnings date
Next Tivic Health Systems earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)